Slides present key points from a Twitter-based journal club, pondering a randomized study of tapering TNF inhibitors in rheumatoid arthritis. Many questions about the study design. More ask about practices already in use (addressed in Part 2).
Expert rheumatologists examine patterns of treatment failure in gout, in light of six recent guidelines on the condition. This brief slide show based on their review summarizes basics about the guidelines and the clues to optimal treatment, linking to the review itself.
Thrombosis risk is increased in lupus, but not all patients are equal in this regard. This slide show summarizes the key points of a new systematic review on the topic that highlights risk assessment and treatment. Full text is available via hyperlinks in the captions.
In the third edition of #rheumjc, author (and Twitter regular) John Cush MD discusses a report from a summit on management of pregnancy and lactation in women with autoimmune and inflammatory diseases.
Lupus is the condition that most frequently requires attention to skin problems, but it's far from the only reason for a rheumatologist's patient to see a dermatologist. In the case of lupus, however, the lesion may be a clue to prognosis.
In its second Twitter-based discussion, the online rheumatology journal club RheumJC pondered a study that shows rituximab effective for relapse in ANCA-associated vasculitis. The 387 "tweets" are reduced here to 11 easy-to-read slides.
Agents that target the TH17-interleukin pathway show promise in psoriatic arthritis, as alternatives for patients who don't benefit from TNFα blockers. This slide show describes their mode of action and potential.
Even if you missed participating in the first-ever rheumatology journal club on Twitter last week at #rheumjc, you can relive the conversation, condensed and edited, in fewer than a dozen slides.
A 35-year-old woman presented with pain in her left foot. Although Morton's neuroma might seem the logical cause, there is a different (and unusual) explanation in this case.
Pulmonary embolism and deep vein thrombosis developed in a 40-year-old man with amyopathic dermatomyositis. D-dimer levels were a red flag.